NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.31
+0.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.73x
- Price / sales
- 15.25x
- Price / cash flow
- -0.00x
Enterprise value
- Enterprise value
- -$1.9M
- EV / sales
- -1.63x
- EV / EBITDA
- 0.15x
- EV / EBIT
- 0.14x
- Market cap
- $17.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026